Thursday, January 06, 2022 10:07:57 AM
https://www.criver.com/insights/charles-river-integrates-cell-and-gene-therapy-acquisitions-enhance-end-end-offering-developers
Best of luck with your investments!
Recent CRL News
- Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research • Business Wire • 09/17/2024 12:00:00 PM
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience • PR Newswire (US) • 09/04/2024 01:21:00 PM
- Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience • Business Wire • 09/04/2024 12:00:00 PM
- Charles River Laboratories to Present at Baird and Morgan Stanley Conferences • Business Wire • 09/03/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 08:17:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 08:13:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/08/2024 05:34:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 01:15:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 11:21:00 AM
- Charles River Laboratories Announces Second-Quarter 2024 Results • Business Wire • 08/07/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/05/2024 08:04:42 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/01/2024 08:07:07 PM
- Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development • Business Wire • 07/30/2024 12:00:00 PM
- Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery • Business Wire • 07/24/2024 12:00:00 PM
- Charles River Laboratories Schedules Second-Quarter 2024 Earnings Release and Conference Call • Business Wire • 07/16/2024 08:30:00 PM
- Charles River to Perform Plasmid Manufacturing for AAVantgarde • Business Wire • 07/08/2024 12:00:00 PM
- Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus • Business Wire • 06/25/2024 12:00:00 PM
- Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy • Business Wire • 06/17/2024 12:00:00 PM
- Charles River Laboratories, in Collaboration With MatTek Corporation, Awarded Grant from the Foundation for Chemistry Research and Initiatives to Advance Research Alternatives • Business Wire • 06/11/2024 12:00:00 PM
- Charles River Laboratories Expands Access to CRADL® Contract Vivarium Space in Somerville • Business Wire • 06/06/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:46:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:25:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:23:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:21:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/04/2024 08:19:35 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM